title: Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion.
abstract: Functional differences between subsarcolemmal and interfibrillar cardiac mitochondria (SSM and IFM) have been observed with aging and pathological conditions in rodents. Results are contradictory, and there is little information from large animal models. We assessed the respiratory function and resistance to mitochondrial permeability transition (MPT) in SSM and IFM from healthy young (1 yr) and old (8 yr) female beagles and in old beagles with hypertension and left ventricular (LV) wall thickening induced by 16 wk of aldosterone infusion. MPT was assessed in SSM and IFM by Ca(2+) retention and swelling. Healthy young and old beagles had similar mitochondrial structure, respiratory function, and Ca(2+)-induced MPT within SSM and IFM subpopulations. On the other hand, oxidative capacity and resistance to Ca(2+)-induced MPT were significantly greater in IFM compared with SSM in all groups. Old beagles treated with aldosterone had greater LV wall thickness and worse diastolic filling but normal LV chamber volume and systolic function. Treatment with aldosterone did not alter mitochondrial respiratory function but accelerated Ca(2+)-induced MPT in SSM, but not IFM, compared with healthy old and young beagles. In conclusion, in a large animal model, oxidative capacity and resistance to MPT were greater in IFM than in SSM. Furthermore, aldosterone infusion increased susceptibility to MPT in SSM, but not IFM. Together this suggests that SSM are less resilient to acute stress than IFM in the healthy heart and are more susceptible to the development of pathology with chronic stress.
authors.affiliation: Division of Cardiology, Department of Medicine, University of Maryland, Baltimore, MD, USA.
authors.forename: Girma
authors.initials: G
authors.lastname: Asemu
authors.forename: Kelly A
authors.initials: KA
authors.lastname: O'Connell
authors.forename: James W
authors.initials: JW
authors.lastname: Cox
authors.forename: Erinne R
authors.initials: ER
authors.lastname: Dabkowski
authors.forename: Wenhong
authors.initials: W
authors.lastname: Xu
authors.forename: Rogerio F
authors.initials: RF
authors.lastname: Ribeiro
authors.forename: Kadambari C
authors.initials: KC
authors.lastname: Shekar
authors.forename: Peter A
authors.initials: PA
authors.lastname: Hecker
authors.forename: Sharad
authors.initials: S
authors.lastname: Rastogi
authors.forename: Hani N
authors.initials: HN
authors.lastname: Sabbah
authors.forename: Charles L
authors.initials: CL
authors.lastname: Hoppel
authors.forename: William C
authors.initials: WC
authors.lastname: Stanley
mesh_terms: D000375:Aging / Q000187:drug effects* / Q000502:physiology*; D000450:Aldosterone / Q000008:administration & dosage / Q000009:adverse effects*; D000818:Animals; D002463:Cell Membrane Permeability / Q000187:drug effects* / Q000502:physiology*; D004285:Dogs; D005260:Female; D006973:Hypertension / Q000139:chemically induced; D017379:Hypertrophy, Left Ventricular / Q000139:chemically induced; D007425:Intracellular Membranes / Q000187:drug effects / Q000502:physiology; D008929:Mitochondria, Heart / Q000187:drug effects* / Q000502:physiology*
chemical_list: D000450:Aldosterone